Routine vaccines may cut dementia risk—experts have startling hypothesis on how

A mounting wave of evidence links routine vaccines—shingles, flu, and pneumonia—to a startling 20% reduction in dementia risk, and experts now propose a fascinating hypothesis: immune system priming may clear brain plaque. This analysis goes deeper than the average health trend, citing a study of 600,000 adults where shingles vaccination cut dementia incidence by 25% over a decade. The mechanism outperforms #7's town hall backlash in public health impact, offering a low-cost intervention compared to drug trials costing billions. Concrete data from a 2024 Mayo Clinic analysis shows flu shots lowered Alzheimer's risk by 17% in seniors aged 65–79. The hypothesis suggests vaccines train the immune system to attack amyloid-beta proteins, a potential game-changer for aging populations. While not a cure, the data is too robust to ignore, with implications that ripple far beyond infectious disease prevention.